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Introduction
Besides its role in locomotion, skeletal muscle also controls whole body energy metabolism and expenditure. Skeletal muscle is a highly plastic tissue composed of slow and fast fibers that exhibit different oxidative and glycolytic metabolic capacities adapting to environmental conditions such as nutrient availability and physical activity. The adaptations of skeletal muscle to physiological stimuli involve changes in mass, myofiber composition, and mitochondrial properties associated with appropriate metabolic modifications. Mitochondria not only produce energy necessary for myofiber contractions, but they are also major producers of ROS. Pathophysiological conditions, such as obesity, type 2 diabetes, and aging, have been associated with impaired skeletal muscle oxidative metabolism and increased ROS production (1, 2) . Conversely, calorie restriction (CR) or exercise both protect from age-related pathologies, notably by decreasing skeletal muscle oxidative stress (3) . Activation of autophagy, a key stress response pathway, is also implicated in the beneficial effects of exercise and CR, notably by preventing the accumulation of damaged cellular components (4) (5) (6) .
Endospanin-1, also named Leptin receptor overlapping transcript (LEPROT), and endospanin-2, also named LEPROT-like 1 (LEPROTL1) (7, 8) , belong to a gene family derived from a unique ancestor gene encoding vacuolar protein sorting 55 (VPS55) in Saccharomyces cerevisiae (9) . The endospanins and VPS55 tetraspan membrane proteins are located in the trans-Golgi network and endosomes and participate in the intracellular trafficking of various proteins, such as cell surface receptors in mammals or vacuolar carboxypeptidase Y in yeast, to the vacuole/lysosome (9-12), suggesting a phylogenetically conserved role of Metabolic stresses such as dietary energy restriction or physical activity exert beneficial metabolic effects. In the liver, endospanin-1 and endospanin-2 cooperatively modulate calorie restrictionmediated (CR-mediated) liver adaptations by controlling growth hormone sensitivity. Since we found CR to induce endospanin protein expression in skeletal muscle, we investigated their role in this tissue. In vivo and in vitro endospanin-2 triggers ERK phosphorylation in skeletal muscle through an autophagy-dependent pathway. Furthermore, endospanin-2, but not endospanin-1, overexpression decreases muscle mitochondrial ROS production, induces fast-to-slow fibertype switch, increases skeletal muscle glycogen content, and improves glucose homeostasis, ultimately promoting running endurance capacity. In line, endospanin-2 -/-mice display higher lipid peroxidation levels, increased mitochondrial ROS production under mitochondrial stress, decreased ERK phosphorylation, and reduced endurance capacity. In conclusion, our results identify endospanin-2 as a potentially novel player in skeletal muscle metabolism, plasticity, and function. these proteins in protein trafficking. We have previously demonstrated that endospanin-1 and endospanin-2 cooperate to decrease cell-surface abundance of the growth hormone (GH) receptor in the liver in periods of reduced nutrient availability, therefore decreasing plasma IGF1 levels (12) . Moreover, endospanin expression is induced in liver and chondrocytes during CR, mediating an FGF-21-dependent reduction in GH sensitivity (13) . Altogether, these observations identify a key role for these proteins in CR-induced metabolic adaptations. Since we found CR to also induce their protein expression in skeletal muscle, we investigated their role in this tissue. Here, using both gain-and loss-of-function models, we demonstrate that endospanin-2, but not endospanin-1, triggers ERK phosphorylation in skeletal muscle through autophagy activation, which results in decreased oxidative stress, fast-to-slow fiber-type switch, and enhanced glucose metabolism and glycogen storage. Finally, we show that endospanin-2 overexpression promotes running endurance capacity, while endospanin-2 downregulation induced the opposite phenotype. These findings identify endospanin-2 as a critical regulator of skeletal muscle plasticity, function, and metabolic flexibility.
Results
CR induces endospanin expression in skeletal muscle. Since CR enhances endospanin expression in the liver and the tibial growth plate in mice (12, 13), we assessed total endospanin expression upon CR in skeletal muscle using antibodies targeting the conserved C-terminus of both endospanin-1 and -2. After 4 weeks of CR, endospanin protein levels increased in skeletal muscle of WT mice (Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.98081DS1), whereas their mRNA levels remained unchanged (Supplemental Figure 1B) . In line, 4 weeks of CR also increased Tg endospanin-2 and endospanin-1 protein but not their mRNA levels in skeletal muscle of endospanin-1 and endospanin-2 Tg mice (Supplemental Figure 1, C-F) . These results indicate that CR upregulates endospanin protein expression through posttranslational mechanisms.
Endospanin-2 decreases mitochondrial oxidative stress. Given the role of CR to preserve skeletal muscle from oxidative damage by decreasing mitochondrial superoxide emission and increasing antioxidant defences (3, 14) , we assessed whether overexpression of endospanins modulate oxidative stress levels. H 2 O 2 plasma levels were 20% lower in endospanin-2 Tg, but not in endospanin-1 Tg mice, when compared with WT littermates ( Figure 1A ). Since other biochemical and functional parameters (data not shown) were also unchanged in endospanin-1 Tg compared with WT littermate mice, we further focused on endospanin-2 Tg mice only. In line with the decrease of plasma H 2 O 2 , levels of malondialdehyde (MDA), a marker of lipid peroxidation, were 50% lower in glycolytic muscles from endospanin-2 Tg compared with WT mice ( Figure 1B ). To determine whether mitochondria are implicated in this oxidative stress reduction, ROS production was measured in isolated mitochondria incubated under stress conditions. Succinate-driven ROS production through reverse electron flow from complex II to complex I was 65% lower in skeletal muscle mitochondria of endospanin-2 Tg mice ( Figure 1C ). Moreover, complex III ROS production measured after addition of the respective complex I and III chain inhibitors, rotenone, and antimycin A was 60% lower in glycolytic muscle mitochondria from endospanin-2 Tg compared with WT mice ( Figure 1C ). In addition, endospanin-2 Tg glycolytic muscle exhibited a 2.8-fold higher catalase activity ( Figure 1D ). To study whether endospanin-2 regulates mitochondrial ROS production in a cell-autonomous manner, C2C12 muscle cells were stably infected with endospanin-1 or endospanin-2 coding retroviruses. In line with the in vivo results, intracellular H 2 O 2 levels measured using 2',7'-dichlorofluorescein diacetate (DCF-DA), a hydrogen peroxide-sensitive fluorescent probe, revealed significantly lower (~30%) ROS production in C2C12 myotubes overexpressing endospanin-2, but not endospanin-1, compared with control infected cells ( Figure 1E ). To confirm that endospanin-2 directly modulates mitochondrial superoxide generation, experiments were performed using MitoSox, a superoxide-specific probe selectively targeted to mitochondria (15) . While antimycin A-driven mitochondrial superoxide production was markedly lower in C2C12 myotubes overexpressing endospanin-2 ( Figure 1F ), endospanin-2 silencing increased antimycin A-stimulated superoxide production ( Figure  1G ). These mitochondrial ROS production modifications were not related to changes in mitochondrial mass or respiration (Supplemental Figure 2) . Interestingly, mRNA and protein expression of UCP3 were lower in endospanin-2 Tg glycolytic muscle (Supplemental Figure 3A) and in endospanin-2-overexpressing C2C12 cells (Supplemental Figure 3B) , likely reflecting an adaptive response to reduced mitochondrial ROS production.
Altogether, these data indicate that endospanin-2 regulates skeletal muscle mitochondrial ROS production. Results are expressed as means ± SEM and were analyzed by unpaired t test, except for E, which was analyzed by 1-way ANOVA. *P < 0.05, **P < 0.01, and ***P < 0.001.
Endospanin-2 activates the ERK pathway.
The ERK pathway is involved in survival processes in response to cellular stresses and also plays an important role in the regulation of mitochondrial function (16, 17) . Since, ERK stimulates Stat3 translocation to mitochondria by enhancing Stat3 phosphorylation on Serine 727, hence downregulating ROS production (18) (19) (20) , we next assessed ERK phosphorylation levels in endospanin-2 Tg muscles. Interestingly, basal ERK1/2 phosphorylation levels were higher in endospanin-2 Tg mice (Figure 2A ), associated with higher Ser 727 Stat3 phosphorylation ( Figure 2B ). Moreover, p-ERK, total ERK, and Stat3 were more abundant in purified skeletal muscle mitochondria from endospanin-2 Tg compared with WT littermate mice ( Figure 2C and Supplemental Figure 4A ). Mitochondrial ERK localization and activity have been associated with mitochondrial permeability transition pore (mPTP) opening desensitization under stress conditions (21) . Interestingly, endospanin-2 overexpression increased the resistance to mPTP opening of isolated skeletal muscle mitochondria, demonstrating higher resistance to cellular stress ( Figure 2D ). ERK phosphorylation was also upregulated in endospanin-2-overexpressing C2C12 cells ( Figure 2E ). In line with these results, the protection from antimycin A-induced superoxide production observed in endospanin-2-overexpressing C2C12 cells was abolished by the addition of U0126, an inhibitor of ERK phosphorylation ( Figure 2F and Supplemental Figure 4B ), suggesting that ERK signaling participates in the endospanin-2-induced decrease of oxidative stress. Together, these data indicate that endospanin-2 regulates mitochondrial ROS production through activation of the ERK pathway.
To determine whether endospanin-2 deficiency leads to a mirror phenotype, endospanin-2 -/-mice were generated (Supplemental Figure 5 , A and B). Opposite to endospanin-2 Tg mice, endospanin-2 -/-mice displayed higher lipid peroxidation levels ( Figure 3A ) and increased mitochondrial ROS production under mitochondrial stress conditions ( Figure 3B ). Consistently, the ERK phosphorylation level was lower in endospanin-2 -/-skeletal muscle ( Figure 3C ). By contrast, AAV-mediated skeletal muscle-specific endospanin-2 overexpression in vivo (Supplemental Figure 5C ) resulted in a significant decrease in mitochondrial ROS production ( Figure 3D ) associated with higher basal ERK phosphorylation levels in skeletal muscle ( Figure 3E ). Altogether, these results demonstrate that skeletal muscle endospanin-2 activates the ERK pathway and regulates mitochondrial ROS production.
Endospanin-2 triggers ERK phosphorylation through autophagy activation. Endospanin-2 Tg mice displayed reduced skeletal muscle mass of the predominant glycolytic muscles (i.e., extensor digitorum longus [EDL], quadriceps, and gastrocnemius) compared with WT mice ( Figure 4A ). Interestingly, this reduction in muscle mass is associated with autophagy activation, a highly conserved cell survival process, linked to dietary restriction and exercise-conveyed skeletal muscle adaptations (22, 23) . Indeed, protein levels of Ulk1, Atg5, Beclin, and the LC3-II/I ratio were increased in glycolytic muscles of endospanin-2 Tg mice ( Figure 4B and Supplemental Figure 6A ). The increase in autophagy was confirmed in vivo by electron microscopy analysis, revealing autophagosome structures in endospanin-2 Tg mouse glycolytic muscles ( Figure 4C ). By contrast, autophagy markers were not increased in the oxidative soleus muscle of endospanin-2 Tg mice compared with WT mice (Supplemental Figure 6B) .
During autophagy, cytoplasmic material and organelles are sequestered within autophagosomes to be delivered to lysosomes for degradation. Since Vps55, the yeast endospanin homologue, promotes targeting of endocytosed proteins to the vacuole/lysosome (9), a key organelle in macroautophagy, we investigated whether cellular endospanin-2 is colocalized with autophagosomes upon modulation of autophagy. In basal conditions, endospanin-2 localized around the nucleus ( Figure 4D and Supplemental Figure 6C ), likely in the endosomal compartment (11) . Interestingly, starvation of endospanin-2-overexpressing C2C12 cells -followed by treatment with chloroquine, a lysosomal inhibitor inducing accumulation of LC3-II-positive autophagosomes -resulted in endospanin-2 colocalization with LC3-II and the lysosome ( Figure 4D and Supplemental Figure 6C ). These results indicate that endospanin-2 traffics with autophagic structures to the lysosome upon autophagy activation.
Interestingly, autophagy has been recently shown to promote ERK phosphorylation (24) . To determine whether endospanin-2 increases ERK phosphorylation through autophagy activation, C2C12 myotubes overexpressing endospanin-2 and control cells were treated with either the PI3K inhibitors wortmannin or chloroquine, which inhibit the autophagy process at early and late stages, respectively. In line with previous observations (24) , blocking autophagosome formation by wortmannin decreased ERK phosphorylation, while chloroquine-induced autophagosome accumulation promoted ERK phosphorylation ( Figure 4E ). More importantly, the difference in ERK phosphorylation observed between endospanin-2-overexpressing and control C2C12 cells was abolished upon inhibition of autophagy by wortmannin and chloroquine ( Figure 4E ). Results are expressed as means ± SEM; *P < 0.05, **P < 0.01, and ***P < 0.001 by unpaired t test.
These data indicate that endospanin-2 regulates ERK phosphorylation through autophagy modulation.
Endospanin-2 regulates skeletal muscle plasticity and function. Considering that oxidative stress level, autophagy activation, and the ERK pathway regulate skeletal muscle plasticity and function (25) (26) (27) , immunofluorescence analysis of the myosin heavy chain (MHC) isoforms was performed on EDL sections of endospanin-2 Tg and WT littermate mice. EDL from endospanin-2 Tg mice exhibited a lower proportion of glycolytic MHC2b and a higher proportion of MHC2x fibers compared with muscles from WT mice ( Figure 5A) . Moreover, the fiber-type switch was observed at both the mRNA and protein levels (Supplemental Figure 7, A and B) . Although the total fiber number remained unchanged (Supplemental Figure  7C) , the MHC2b fiber cross-section area (CSA) was significantly lower, while the MHC2x and hybrid fiber CSA was higher in EDL of endospanin-2 Tg compared with WT mice ( Figure 5B ). This fiber-type switch was not observed in the soleus oxidative muscle of endospanin-2 Tg compared with WT mice (Supplemental Figure 7D ). Moreover, skeletal muscle fiber type and mass were not yet modified in young endospanin-2 . (E) Western blot analysis of phosphorylated ERK 1/2 and total ERK1/2 protein levels in endospanin-2 or control (pBabe) retrovirus-infected C2C12 cells cultured in nutrient-free medium (HBSS) treated with chloroquine (50μM), wortmannin (100 nM), or their respective vehicle for 4 hours (n = 3 per condition). Results are expressed as means ± SEM; *P < 0.05, **P < 0.01, and ***P < 0.001 by unpaired t test.
Tg mice compared with WT and endospanin-1 Tg mice (Supplemental Figure 7 , E and F), suggesting that the endospanin-2-induced skeletal muscle phenotype is unlikely to be established during development.
By contrast, glycolytic muscles of endospanin-1 Tg mice did not display any phenotype and displayed no modification in fiber-type composition (Supplemental Figure 7 , A and B) or mass (data not shown) compared with WT mice.
To investigate whether the fiber-type transition in endospanin-2 Tg mice is associated with changes in skeletal muscle function, the fatigue index was evaluated on dissected EDL from endospanin-2 Tg and WT mice. Consistent with the fast-to-slow fiber type, ex vivo endospanin-2 Tg EDL muscle was significantly more resistant to fatigue than EDL from WT mice ( Figure 5C ). Since metabolic challenges also impact skeletal muscle metabolism, we measured skeletal muscle glycogen level, an easily mobilized source of glucose upon sudden energy needs. Periodic acid-Schiff (PAS) staining ( Figure 5D and Supplemental Figure  8A ) and biochemical measurement of glycogen (Supplemental Figure 8B ) revealed a significantly higher glycogen content in glycolytic muscles of endospanin-2 Tg mice compared with WT littermates. Given these findings, we also assessed whether endospanin-2 overexpression affects glucose homeostasis. Despite no changes in plasma insulin level (Supplemental Figure 8C) , fasting plasma glucose was lower in endospanin-2 Tg mice (Supplemental Figure 8D) , and this was associated with improved glucose tolerance ( Figure  5E and Supplemental Figure 8E ). Moreover, insulin-stimulated p-Akt levels were more strongly induced in skeletal muscle of endospanin-2 Tg mice compared with WT mice, indicating that skeletal muscle of endospanin-2 Tg mice are more sensitive to insulin than WT mice ( Figure 5F and Supplemental Figure 8F ). By contrast, endospanin-2 -/-mice did not display any difference in glucose homeostasis compared with their WT littermates (Supplemental Figure 8G) .
Finally, when submitted to an endurance exercise test to exhaustion at 70% of maximal oxygen consumption (VO 2max ), endospanin-2 Tg mice ran much longer and covered a greater distance than WT or endospanin-1 Tg mice ( Figure 5G and Supplemental Figure 8H ), while endospanin-2 -/-mice displayed lower exercise capacity ( Figure 5H and Supplemental Figure 8I ) and reduced spontaneous locomotor activity in a free wheel exercise compared with their WT littermates (Supplemental Figure 8J) . Altogether, these data show that endospanin-2 plays a regulatory role in skeletal muscle metabolic flexibility and function.
Discussion
Dietary energy restriction is a metabolic stress that induces beneficial adaptations of skeletal muscle, resulting in improved health (28) . We and others have previously shown that endospanin-1 and endospanin-2 cooperatively control CR-induced metabolic adaptations in the liver by modulating hepatic GH sensitivity (12, 13) . In this study, we show that endospanin-2, but not endospanin-1, modulates skeletal muscle function and plasticity. By activating autophagy, endospanin-2 triggers ERK phosphorylation, which leads to decreased mitochondrial ROS production, fast-to-slow fiber-type switch, and enhanced running capacity. Selective AAV-mediated overexpression of endospanin-2 in skeletal muscle reduces oxidative stress and decreases ERK phosphorylation, highlighting that endospanin-2 exerts a direct action in this tissue. Moreover, endospanin-2 Tg mice display increased skeletal muscle glycogen content, increased skeletal muscle insulin sensitivity, and improved glucose homeostasis, suggesting that endospanin-2 promotes skeletal muscle metabolic flexibility to sustain energy production during physical activity. Overall, we show that endospanin-2 overexpression mimicks the beneficial adaptations of skeletal muscle to metabolic challenges (29) (30) (31) (32) .
CR and/or exercise-mediated antioxidant activities preserve cellular and mitochondrial functions (14) . Using both loss-and gain-of-function experiments, we show that endospanin-2 increases oxidative stress resistance, as illustrated by decreased mitochondrial ROS production and increased antioxydant enzyme expression. In line, skeletal muscle UCP3 expression is decreased in endospanin-2 Tg mice, which likely reflects an adaptive response to reduced mitochondrial ROS production (33) . Indeed, UCP3 expression is reduced upon endurance training and is negatively correlated with energy efficiency (34) .
To decipher the mechanism of action of endospanin-2, which is a tetraspan membrane protein, we assessed signaling pathways of cytosolic-to-mitochondrial signaling. Interestingly, the transient stress induced by resistance exercise activates the ERK pathway (35, 36) . Moreover, ERK activation induces fast-to-slow fiber-type transition (27) , whereas ERK inhibition decreases slow fiber-type isoforms in vitro (37) . Our results demonstrate that overexpression or downregulation of endospanin-2 in vivo and in vitro modulates basal ERK activation. Since in vivo endospanin-2 overexpression is also associated with a fastto-slow fiber-type switch, higher resistance to fatigue, and enhanced endurance capacity, ERK signaling is likely to mediate the endospanin-2-induced skeletal muscle adaptations. Active ERK phosphorylates Stat3 on Serine 727, leading to Stat3 translocation to mitochondria, where it directly modulates the mitochondrial complex I to lower ROS production (20, 38, 39) . Increased amounts of total and phosphorylated ERK and total Stat3 were found in skeletal muscle mitochondria from endospanin-2 Tg mice. Moreover, in vitro inhibition of ERK phosphorylation by U0126 reversed the endospanin-2-induced decrease in superoxide production, demonstrating that the reduction in mitochondrial ROS production by endospanin-2 requires activation of the ERK pathway. In addition, mitochondrial localization of ERK is also associated with decreased mitochondrial PTP opening sensitivity (21) , which reduces cell susceptibility to apoptosis. Our data show that endospanin-2 reduces mPTP opening susceptibility. Thus, activation of the ERK pathway provides a mechanism through which endospanin-2 initiates a protective response conferring higher resistance to cellular stress associated with decreased mitochondrial ROS production.
Metabolic stress activates autophagy, a highly conserved cell survival process, to minimize damages and to provide energy for short-term survival. This process is essential for dietary restriction and exercise-conveyed skeletal muscle adaptations (22, 23) . Indeed, deficiency in skeletal muscle autophagy results in impaired metabolic adaptations to exercise, decreased endurance capacity, and exacerbated age-related skeletal muscle dysfunctions (5, 40) . Western blot and electron microscopy analysis of endospanin-2-overexpressing skeletal muscles revealed activated autophagy in glycolytic, but not in oxidative muscle, suggesting that endospanin-2 preserves skeletal muscle function by inducing glycolytic muscle-selective autophagy, a process resembling starvation-and/or exercise-induced autophagy (41) . Interestingly, exercise did not further increase autophagy markers in endospanin-2 Tg mice skeletal muscle (data not shown), indicating that endospanin-2 Tg mice display a constitutive increase in autophagy, as observed upon exercise. Moreover, chloroquine treatment delocalizes endospanin-2 from the endosomal compartment to the lysosome, where it colocalizes with LC3-II-positive autophagosomes. Interestingly, autophagic structures serve as cellular platforms promoting ERK phosphorylation (24) . Our results show that inhibition of autophagy, either at early or late stages, abolished the altered ERK phosphorylation levels in endospanin-2-overexpressing C2C12 cells, indicating that endospanin-2 regulates ERK phosphorylation levels through autophagy activation. Interestingly, global phosphorylated protein analysis in yeast found a physical interaction between Vps55 (the endospanins yeast homologue) and the serine/threonine kinase ATG1 (the Ulk1 yeast homologue), a key protein involved in the initiation of autophagy following starvation (42) . Moreover, Vps55 mutants display decreased oxidative and chemical stress resistance (43) , as well as decreased sporulation capacity in response to starvation (44) . Altogether, our results indicate that endospanin-2, by modulating autophagosome trafficking to the lysosome, activates autophagy and triggers ERK phosphorylation to increase cellular stress resistance.
In conclusion, our data show that endospanin-2 expression is induced in skeletal muscle during CR and that endospanin-2 overexpression, by activating autophagy-mediated ERK phosphorylation, decreases mitochondrial oxidative stress and modulates skeletal muscle function. This study supports a prominent role of endospanin-2 in skeletal muscle plasticity and metabolic flexibility, resulting in enhanced running capacity.
Methods
Supplemental Methods are available online with this article.
Mice. We used Tg human endospanin-1 and endospanin-2 male mice on a C57Bl/6 background, which overexpress human endospanin-1 (or LEPROT) and endospanin-2 (or LEPROTL1) in all tissues, including skeletal muscle, as previously described (12) . Endospanin-2-KO (or Leprotl1) mice were generated using Mice were backcrossed with C57BL/6J for 10 generations, and heterozygotes were inbred (see Supplemental informations). Male and female mice were used at 15-20 weeks of age. All mice were housed in a 12-hour/12-hour light/dark cycle, and the ad libitum-fed (AL-fed) group had free access to water and regular chow diet (A03; Usine d'Alimentation Rationelle), but CR mice were fed at 70% of the food intake of their AL-fed littermates during 4 weeks.
Cell culture. Mouse C2C12 myoblasts (CRL-1772, American Type Culture Collection) were cultured in DMEM (4.5 g/l D Glucose; Gibco) supplemented with 10% FBS and 1% gentamycin at 37°C and 5% CO 2 . C2C12 cells allowed to reach 90% of confluence were differentiated into myotubes by adding DMEM supplemented with 2% horse serum (HS) during 5 days. Cell lines constitutively overexpressing endospanin-1 and endospanin-2 were generated as previously described (45) . Endospanin-1 and endospanin-2 overexpression was verified by quantitative PCR (qPCR) and Western blot on endospanin-1 and endospanin-2 C2C12 cells compared with pBabe control cells. For autophagy experiments, cells were cultured in HBSS and either treated with wortmannin (Merck, 100 nM) or chloroquine (Merck, 50 μM) or their respective vehicle for 4 hours.
Mitochondrial ROS production in plasma and isolated mitochondria. H 2 O 2 production from plasma and skeletal muscle mitochondria was measured fluorimetrically using Amplex Red (Molecular Probes, Invitrogen). Mitochondria (30 μg of mitochondrial proteins/well) were incubated in mitochondrial respiration medium (Mir05) in the presence of the respiratory chain complex II substrate succinate (Merck, 10 mM), with or without complex I and III inhibitors -i.e., rotenone (Merck, 1 μM) and antimycin A (Merck, 2.5 μM), respectively. Reactions were set up in triplicate in the presence of 50 μM of Amplex Red and 0.1 unit/ ml horseradish peroxidase in a 96-well plate. Fluorescence (excitation wavelength λ ex =545 nm, emission wavelength λ em =590 nm) was kinetically followed during 30 minutes at 37°C, using a Tecan Infinite F500 apparatus (Tecan Systems). For quantification, 2 wells containing 10 μM H 2 O 2 were added on each plate. All results were expressed in nmol of produced H 2 O 2 per mg of mitochondrial proteins per minute.
Mitochondrial swelling assay. Mitochondrial swelling consecutive to PTP opening was monitored by the decrease of 90° light scatter at 540 nm in a spectrophotometer as described (46) . Briefly, a mitochondrial pellet was suspended in swelling buffer (0.4 mg/ml), and 200 μl/well was added in a 96-well plate. A PTP opening was induced by the addition of 75 μM Ca 2+ . MHC immunofluorescence. Conventional immunofluorescence for MHC subtyping was performed on transverse cryosections of EDL and Soleus muscle. MHC2a, visualized in green, was stained using a monoclonal antibody (N2.261, Developmental Studies Hybridoma Bank) directed against human neonatal MHC human neonatal slow type 1 and type 2a. MHC2x, visualized in red, was stained using a mouse IgM polyclonal antibody directed against rabbit MHC type 2x (6H1, Developmental Studies Hybridoma Bank). Individual muscle fibers were visualized using a primary antibody against the basement membrane marker laminin (rabbit polyclonal antibody, L-9393, Merck), which was visualized in blue. The following secondary antibodies were used: for the myosin 1/2a a goat anti-mouse IgG1 AlexaFluor 488 (A-21121, Thermo Fisher Scientific), for the myosin 2x a goat anti-mouse IgM AlexaFLuor 555 (A-21426, Thermo Fisher Scientific), for the laminin a goat anti-rabbit IgG AlexaFluor 350 (A-11069, Thermo Fisher Scientific).
Maximal exercise stress test and endurance capacity. Mice were acclimated to the treadmill by performing a 10 m/min run 2 days prior to the experiment. The day of the exercise stress test, mice were placed onto the treadmill enclosed in a metabolic chamber connected to an O 2 sensor (Oxymax, Columbus Instruments). Basal VO 2 (VO 2b ) was measured after a 30-minute resting period, and then mice started running at 10 m/ min in a 0% incline. Speed was incremented by 4 m/min every 3 minutes until exhaustion in order to determine their VO 2max . Exhaustion was reached when mice remained on the electrical shocker plate for 5 seconds. Speed corresponding to VO 2max was determined and considered as the maximal running speed (v max ). Two days later, mice ran at a speed equivalent to 70% of their v max until exhaustion in order to determine their maximal endurance capacity. Time to exhaustion and total run distance were determined.
Daily wheel-running activity. To analyze daily wheel-running activity, mice were placed into individual cages containing running wheels for 1 week (Campden, Phymep). Wheel revolution was recorded daily and averaged.
Statistics. Values are means ± SEM of the indicated number of measurements. Statistical significance was determined using 2-tailed unpaired Student's t test or 1-way ANOVA with P < 0.05.
Study approval. Experimental protocols were performed with the approval of the Nord Pas de Calais ethics committee (CEEA75) and in compliance with French and European ethical legislations.
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